GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Other Income (Expense)

MindBio Therapeutics (XCNQ:MBIO) Other Income (Expense) : C$0.03 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Other Income (Expense)?

MindBio Therapeutics's other income expense for the MindBio Therapeutics's pretax income for the three months ended in Dec. 2024 was C$-0.01 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.03 Mil.

MindBio Therapeutics Other Income (Expense) Historical Data

The historical data trend for MindBio Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Other Income (Expense) Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
- -1.54 -0.60 -

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 -0.04 -0.02 0.09 -0.01

MindBio Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindBio Therapeutics  (XCNQ:MBIO) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

MindBio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Other Income (Expense)
Comparable Companies
XCNQ:HEAL XCNQ:ENBI XCNQ:RIZE XCNQ:MOOD XCNQ:AGN TSXV:WAVE XCNQ:NSHS XCNQ:NIRV XCNQ:CHGX XCNQ:MYND VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
WF6:Germany
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
Website
https://www.mindbiotherapeutics.com
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.
Executives
Accelerative Investments Pty Ltd Director